Andre Couturier

Collaborated with 417 co-authors with over 1500 citations

- Matthews DR, Dejager S, Ahren B, Fonseca V, Ferrannini E, Couturier A, Foley JE, Zinman B. (2010). Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study. Diabetes Obes Metab. 12(9):780-9.PMID: 20649630
- Kikuchi M, Haneda M, Koya D, Tobe K, Onishi Y, Couturier A, Mimori N, Inaba Y, Goodman M. (2010). Efficacy and… Show more

Collaborated with 417 co-authors with over 1500 citations

- Matthews DR, Dejager S, Ahren B, Fonseca V, Ferrannini E, Couturier A, Foley JE, Zinman B. (2010). Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study. Diabetes Obes Metab. 12(9):780-9.PMID: 20649630
- Kikuchi M, Haneda M, Koya D, Tobe K, Onishi Y, Couturier A, Mimori N, Inaba Y, Goodman M. (2010). Efficacy and tolerability of vildagliptin as an add-on to glimepiride in Japanese patients with Type 2 diabetes mellitus. Diabetes Res Clin Pract. 89(3):216-23.PMID: 20537746
- Ligueros-Saylan M, Foley JE, Schweizer A, Couturier A, Kothny W. (2010). An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials. Diabetes Obes Metab. 12(6):495-509.PMID: 20518805
- Schweizer A, Dejager S, Foley JE, Couturier A, Ligueros-Saylan M, Kothny W. (2010). Assessing the cardio-cerebrovascular safety of vildagliptin: meta-analysis of adjudicated events from a large Phase III type 2 diabetes population. Diabetes Obes Metab. 12(6):485-94.PMID: 20518804
- Garber, A.J., et al. (2008). Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with sulphonylurea. Diabetes Obesity and Metabolism, 10(11):1047-56.
- Schweizer, A., et al. (2007). Comparison between vildagliptin and metformin to sustain reductions in HbA 1c over 1 year in drug-naïve patients with Type 2 diabetes. Diabetic Medicine, 24 (9): 955-961.
- Ciampi, A., Couturier, A., Li, S. (2002). Prediction trees with soft nodes for binary outcomes. Statist. Med. 21:1145-65.

and more... Show less